FORM 38.5(b)(EPT/NON-RI)
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE/DEALING DISCLOSURE
UNDER RULE 38.5(b) AND RULE 38.6 OF THE IRISH TAKEOVER
PANEL ACT, 1997, TAKEOVER RULES, 2022 BY A CONNECTED
EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED
INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY
STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
| (a) Name of exempt principal trader: |
Morgan Stanley Europe SE |
| (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree |
Avadel Pharmaceuticals plc |
| (c) Name of the party to the offer with which exempt principal trader is connected: (Note 1) |
Avadel Pharmaceuticals plc |
| (d) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure |
09 January 2026 |
| (e) In addition to the company in 1(b) above, is the exempt principal trader also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" |
N/A |
2. INTERESTS AND SHORT POSITIONS
If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2 for each additional class of relevant security.
Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) (Note 2)
| Class of relevant security: |
0.01 ordinary shares |
|||
| |
Interests |
Short positions |
||
| Number |
% |
Number |
% |
|
| (1) Relevant securities owned and/or controlled: |
0 |
0.00 |
0 |
0.00 |
| (2) Cash-settled derivatives: |
0 |
0.00 |
0 |
0.00 |
| (3) Stock-settled derivatives (including options) and agreements to purchase/ sell: |
0 |
0.00 |
0 |
0.00 |
| Total: |
0 |
0.00 |
0 |
0.00 |
All interests and all short positions should be disclosed.
Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.
3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(Note 4)
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
| Class of |
Purchases/ |
Total |
Highest |
Lowest |
| 0.01 ordinary shares |
PURCHASES |
4,000 |
21.5100 USD |
21.5100 USD |
| 0.01 ordinary shares |
SALES |
4,000 |
21.5100 USD |
21.5100 USD |
(b) Cash-settled derivative transactions
| Class of |
Product |
Nature of dealing |
Number of |
Price per |
| N/A |
N/A |
N/A |
N/A |
N/A |
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
| Class of |
Product |
Writing, |
Number of |
Exercise |
Type |
Expiry |
Option |
| N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
(ii) Exercise
| Class of |
Product |
Exercising/ |
Number of |
Exercise |
| N/A |
N/A |
N/A |
N/A |
N/A |
(d) Other dealings (including transactions in respect of new securities)
| Class of |
Nature of |
Details |
Price per unit |
| N/A |
N/A |
N/A |
N/A |
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
| Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none" |
| NONE |
(b) Agreements, arrangements or understandings relating to options or derivatives
| Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. |
| NONE |
(c) Attachments
| Is a Supplemental Form 8 attached? |
NO |
| Date of disclosure: |
12 January 2026 |
| Contact name: |
Claire Gordon |
| Telephone number: |
+44 141 245-8893 |
Public disclosures under Rule 38 of the Rules must be made to a Regulatory Information Service.